THE
WALL STREET JOURNAL.
|
Opinion
Letters
The Trian Fund Protests Too Much
DuPont’s
soaring current performance predates any Trian involvement.
April 16, 2015
I want to correct any
misconceptions from Trian CIO Ed Garden’s April 10 letter regarding my
April 2 op-ed
“Activist Shareholders, Sluggish
Performance.” I am more focused on the mediocre performance
following Trian Fund Management’s board service than its investor
success. An investor should care what happens beyond the media drama
of the initial investment’s stock pop.
The entire costly,
distracting
DuPont proxy battle is over Trian
founder
Nelson Peltz’s requirement that
he or his principals serve on the DuPont board. So what happens when
they join boards? Five out of 11 boards Trian has joined since Trian’s
inception well underperformed the S&P 500 during the period of its
service.
Trian had multiple
disasters in the chemical industry, including when, in 2009, it quit
the board of chemical company
Chemtura
a week before Chemtura declared
bankruptcy.
While DuPont’s proxy
battle isn’t about how Trian performs as an investor, looking over the
past three years, Trian’s cumulative returns at 54% are far below the
S&P 500 at 74.6% and far lower than several leading activist funds.
That is not cherry-picking random years. Trian filed an SEC correction
April 3 on Mr. Peltz’s performance overstatement.
DuPont’s soaring current
performance predates any Trian involvement. Does Trian want to suggest
it inspired DuPont’s engine of innovation through history such as
nylon, rayon, Teflon, Mylar, Neoprene, Tyvek and Lycra?
This 212-year-old global
icon is one of the top three largest, most profitable, efficient,
integrated chemical companies in the world, whose continuing
innovation, employment and economic contributions should be
celebrated, not hacked up in fire-sale auctions.
Prof. Jeffrey A.
Sonnenfeld
Yale School of Management
New Haven, Conn.
|